{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:19:21Z","timestamp":1780319961297,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T00:00:00Z","timestamp":1452038400000},"content-version":"vor","delay-in-days":1772,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1097\/jto.0b013e31820b9b35","type":"journal-article","created":{"date-parts":[[2011,2,2]],"date-time":"2011-02-02T07:37:09Z","timestamp":1296632229000},"page":"606-613","source":"Crossref","is-referenced-by-count":13,"title":["Expression of Excision Repair Cross-Complementation Group 1, Breast Cancer Susceptibility 1, and \u03b2 III-Tubulin in Thymic Epithelial Tumors"],"prefix":"10.1016","volume":"6","author":[{"given":"Kyoichi","family":"Kaira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakuni","family":"Serizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieko","family":"Kaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Ohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tateaki","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruyasu","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e31820b9b35_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States. Demographic patterns in incidence and associations with subsequent malignancies","volume":"105","author":"Engels","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib2","series-title":"Histological Typing of Tumours of the Thymus, International Histological Classification of Tumours","first-page":"1","author":"Rosai","year":"1999"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib3","series-title":"WHO Classification of Tumors. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart","author":"Travis","year":"2004"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00000421-200206000-00012","article-title":"Chemotherapy for advanced thymic carcinoma. clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy)","volume":"25","author":"Koizumi","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib5","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/cncr.11606","article-title":"Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma","volume":"98","author":"Yok","year":"2003","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.lungcan.2009.03.031","article-title":"Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma","volume":"67","author":"Igawa","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1097-2765(01)00281-7","article-title":"Sequential assembly of the nucleotide excision repair factors in vivo","volume":"8","author":"Volker","year":"2001","journal-title":"Mol Cell"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib8","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1378\/chest.127.3.978","article-title":"ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer","volume":"127","author":"Simon","year":"2005","journal-title":"Chest"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib9","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa065411","article-title":"DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer","volume":"356","author":"Zheng","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17530059.2010.506214","article-title":"Prognostic and predictive factors in resected non-small cell lung cancer","volume":"4","author":"Kaira","year":"2010","journal-title":"Expert Opin Med Diagn"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.lungcan.2009.07.004","article-title":"The prognostic significance of ERCC1, XRCC1, and \u03b2 III-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection","volume":"68","author":"Kang","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.lungcan.2010.05.010","article-title":"The platinum-based treatments for advanced non-small cell lung cancer, is low\/negative ERCC1 expression better than high\/positive ERCC1 expression? A meta-analysis","volume":"70","author":"Chen","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/JTO.0b013e3181ce684f","article-title":"Expression of class III beta-tubulin correlates with unfavorable survival outcome in patients with resected non-small cell lung cancer","volume":"5","author":"Koh","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib16","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/JTO.0b013e3181ca063b","article-title":"ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung. distribution and impact on survival","volume":"5","author":"Skov","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib18","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2009.27.4662","article-title":"Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors","volume":"28","author":"Kaira","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1097-2765(01)00281-7","article-title":"Sequential assembly of the nucleotide excision repair factors in vivo","volume":"8","author":"Volker","year":"2001","journal-title":"Mol Cell"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib21","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/jnci\/84.19.1512","article-title":"ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients","volume":"84","author":"Dabholkar","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib22","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1200\/JCO.2001.19.23.4298","article-title":"ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy","volume":"19","author":"Shirota","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1200\/JCO.1998.16.1.309","article-title":"ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy","volume":"16","author":"Metzger","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib24","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1158\/1078-0432.CCR-04-1387","article-title":"High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer","volume":"11","author":"Joshi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib25","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.ejca.2010.02.045","article-title":"ERCC1 and toxicity and quality of life in advanced NSCLC patients randomized in a large multicentre phase III trial","volume":"46","author":"Vilmar","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(02)11087-7","article-title":"BRCA1. mechanisms of inactivation and implications for management of patients","volume":"360","author":"Kennedy","year":"2002","journal-title":"Lancet"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib27","doi-asserted-by":"crossref","first-page":"e1129","DOI":"10.1371\/journal.pone.0001129","article-title":"BRCA1. A novel prognostic factor in resected non-small cell lung cancer","volume":"2","author":"Rosell","year":"2007","journal-title":"Plos One"},{"key":"10.1097\/JTO.0b013e31820b9b35_bib28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1470-2045(08)70029-9","article-title":"Is class III \u03b2-tubulin a predictive factor in patients receiving tybulin-binding agents?","volume":"9","author":"Seve","year":"2008","journal-title":"Lancet Oncol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155608641532219X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155608641532219X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T20:39:05Z","timestamp":1657744745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155608641532219X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S155608641532219X"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e31820b9b35","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}